Publications by Year: 2018

2018
A. A. Deshmukh, S. M. Shirvani, A. Likhacheva, J. Chhatwal, E. Y. Chiao, and K. Sonawane. 2018. “The Association Between Dietary Quality and Overall and Cancer-Specific Mortality Among Cancer Survivors, NHANES III.” JNCI Cancer Spectr, 2, 2, Pp. pky022.
J. Chhatwal and F. Kanwal. 2018. “Cost-effectiveness and Decision Analysis in Clinical Gastroenterology and Hepatology: From Evidence to Informed Decision Making.” Clin Gastroenterol Hepatol, 16, 4, Pp. 459-461.
A. Goel, Q. Chen, J. Chhatwal, and R. Aggarwal. 2018. “Cost-effectiveness of generic pan-genotypic sofosbuvir/velpatasvir versus genotype-dependent direct-acting antivirals for hepatitis C treatment.” J Gastroenterol Hepatol, 33, 12, Pp. 2029-2036.
J. Chhatwal, Q. Chen, and R. Aggarwal. 2018. “Estimation of Hepatitis C Disease Burden and Budget Impact of Treatment Using Health Economic Modeling.” Infect Dis Clin North Am, 32, 2, Pp. 461-480.
A. C. Spaulding, M. G. Adee, R. T. Lawrence, J. Chhatwal, and W. von Oehsen. 2018. “Five Questions Concerning Managing Hepatitis C in the Justice System: Finding Practical Solutions for Hepatitis C Virus Elimination.” Infect Dis Clin North Am, 32, 2, Pp. 323-345.
J. Chhatwal, Q. Chen, E. D. Bethea, M. A. Ladd, P. P. Mueller, Y. Hutin, and R. Aggarwal. 2018. “Hep C Calculator: an online tool for cost-effectiveness analysis of DAAs.” Lancet Gastroenterol Hepatol, 3, 12, Pp. 819.
J. Chhatwal. 2018. “Hepatitis C Screening: From Modeling to Public Health Policy.” Clin Infect Dis, 66, 3, Pp. 385-386.
Qiushi Chen, Turgay Ayer, and Jagpreet Chhatwal. 2018. “Optimal M-Switch surveillance policies for liver cancer in a Hepatitis C–infected population.” Operations Research, 66, 3, Pp. 673-696.
E. D. Bethea, Q. Chen, C. Hur, R. T. Chung, and J. Chhatwal. 2018. “Should we treat acute hepatitis C? A decision and cost-effectiveness analysis.” Hepatology, 67, 3, Pp. 837-846.
J. Chhatwal, S. Samur, E. D. Bethea, T. Ayer, F. Kanwal, C. Hur, M. S. Roberts, N. Terrault, and R. T. Chung. 2018. “Transplanting hepatitis C virus-positive livers into hepatitis C virus-negative patients with preemptive antiviral treatment: A modeling study.” Hepatology, 67, 6, Pp. 2085-2095.
R. Suk, P. Mahale, K. Sonawane, A. G. Sikora, J. Chhatwal, K. M. Schmeler, K. Sigel, S. B. Cantor, E. Y. Chiao, and A. A. Deshmukh. 2018. “Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers.” JAMA Netw Open, 1, 5, Pp. e181999.